Primary Menu
Skip to content
Team
Leadership
Board of Directors
Scientific Advisory Board
Science
Pipeline
BNZ-1
BNZ-2
BNZ-3
News
Contact
News
Bioniz Announces Positive End of Phase 2 Meeting with the FDA for BNZ-1 for the Treatment of Refractory Cutaneous T-Cell Lymphoma
January 4, 2021
Bioniz Announces Positive Clinical Data of BNZ-1, First Anti-Cytokine Therapy to Demonstrate Efficacy in Treating Refractory Cutaneous T-Cell Lymphoma
December 5, 2020
Bioniz Announces Oral Presentation at ASH 2020 of Positive Clinical Data of BNZ-1 for the Treatment of Refractory Cutaneous T-Cell Lymphoma
November 5, 2020
Bioniz announces positive efficacy and safety data for BNZ-1 from interim analysis of phase 1/2 study in cutaneous T-cell lymphoma
July 20, 2020
Bioniz Therapeutics enters into an option agreement for acquisition by Almirall of its lead clinical candidate BNZ-1 in development for immuno-dermatologic and onco-dermatologic diseases
January 9, 2020
Bioniz Therapeutics Announces Positive Phase 1b Clinical Study Results for Investigational Agent BNZ-1
May 1, 2018
Bioniz Therapeutics Initiates Phase 1/2 Clinical Study of BNZ 1 in T-Cell Leukemia and Lymphoma
April 4, 2018
Bioniz Therapeutics Appoints Graham Cooper to its Board of Directors
December 6, 2017
Bioniz Therapeutics to Present New Data at the 2017 ASH Annual Meeting
November 2, 2017
Bioniz Therapeutics Presents Data Demonstrating the Synergistic Effects of Cytokines IL-15 and IL-21 in Celiac Disease Pathogenesis
September 13, 2017
Bioniz Therapeutics Reports Top-Line Phase 1 Clinical Study Results for BNZ-1, A Novel Multi-Cytokine Inhibitor
July 19, 2017
Bioniz Therapeutics Appoints Paul Frohna M.D., Ph.D., Pharm. D., as Senior Vice President of Clinical Development
December 20, 2016
Bioniz Therapeutics Closes Series A Financing and Appoints David Pyott as Chairman of the Board of Directors
August 1, 2016
Bioniz Therapeutics Appoints Fredrik Wiklund as Chief Operating Officer
May 3, 2016
Eric Carter, M.D., PH.D. Former CMO of Allergan, Joins Bioniz Therapeutics as Chairman of the Scientific and Clinical Advisory Board
April 12, 2016
Bana Jabri to Join Bioniz SAB
November 3, 2015
Publications Announced In JBC and PNAS
October 6, 2015
Team
Leadership
Board of Directors
Scientific Advisory Board
Science
Pipeline
BNZ-1
BNZ-2
BNZ-3
News
Contact